The quarter's dismal performance stands in stark contrast to the company's earlier trajectory, with the full-year FY25 having delivered modest profitability. The sharp deterioration has pushed the stock down 52.63% over the past year, significantly underperforming both the Sensex and its Trading & Distributors sector peers. Trading at ₹4.69 as of June 1, 2026, the stock has plunged 8.75% in a single day following the results announcement, reflecting investor alarm at the operational collapse.
The company's proprietary Mojo Score stands at a dismal 9 out of 100, firmly in "Strong Sell" territory, whilst technical indicators paint an equally grim picture with a "Mildly Bearish" trend and the stock trading below all major moving averages. With minimal institutional interest (just 0.33% holdings) and promoters holding only 18.50%, the stock lacks the support base typically needed for a turnaround.
| Quarter | Revenue (₹ Cr) | QoQ Change | Net Profit (₹ Cr) | QoQ Change | PAT Margin |
|---|---|---|---|---|---|
| Mar'26 | 2.95 | N/A | -6.17 | -2273.08% | -209.15% |
| Dec'25 | 0.00 | -100.00% | -0.26 | -252.94% | 0.0% |
| Sep'25 | 0.00 | -100.00% | -0.17 | -170.83% | 0.0% |
| Jun'25 | 13.37 | -28.00% | 0.24 | +41.18% | 1.80% |
| Mar'25 | 18.57 | +81.88% | 0.17 | +13.33% | 0.92% |
| Dec'24 | 10.21 | -49.56% | 0.15 | -82.76% | 1.47% |
| Sep'24 | 20.24 | N/A | 0.87 | N/A | 4.30% |
Financial Performance: A Quarter of Complete Breakdown
In Q4 FY26, Newtrac Foods' financial metrics collapsed across every parameter. Net sales of ₹2.95 crores represented an 84.11% year-on-year decline from ₹18.57 crores in Q4 FY25, whilst on a sequential basis, the company had reported zero revenues in both Q3 and Q2 FY26, making the March quarter's minimal sales a marginal improvement over an extremely low base.
The operating profit (PBDIT excluding other income) turned catastrophically negative at ₹-6.18 crores versus a positive ₹0.97 crores in the year-ago period, resulting in an operating margin of -209.49%. This represents the lowest operating performance in the company's recent history. The profit before tax stood at ₹-6.17 crores compared to ₹0.90 crores in Q4 FY25, a complete reversal of fortunes.
Interestingly, the company reported zero tax expense for the quarter, consistent with its loss-making status. Other income of ₹0.07 crores provided minimal cushion against the operational losses. The PAT margin of -209.15% underscores the severity of the operational challenges, with losses exceeding revenues by more than double.
The full-year FY25 picture provides context: the company had reported revenues of ₹64.00 crores with a net profit of ₹1.00 crore and operating margins of 3.10%. The dramatic deterioration in FY26, with two quarters of zero revenues and the fourth quarter's massive loss, suggests fundamental operational disruption rather than cyclical weakness.
Operational Challenges: Business Model Under Severe Stress
The company's balance sheet reveals concerning trends. Shareholder funds stood at ₹11.18 crores as of March 2025, a significant improvement from negative ₹5.02 crores in March 2024, primarily driven by a capital infusion that increased share capital from ₹4.80 crores to ₹19.20 crores. However, reserves remain negative at ₹-8.02 crores, indicating accumulated losses.
Current liabilities of ₹16.22 crores include trade payables of ₹8.95 crores, suggesting working capital pressures. Current assets stood at ₹27.39 crores, providing a current ratio of approximately 1.69, which offers some liquidity comfort. The company maintains minimal fixed assets (₹0.02 crores) and zero long-term debt, consistent with its trading and distribution business model.
Return on Equity (ROE) tells a troubling story: whilst the average ROE over recent years stands at 16.01%, the latest ROE has plummeted to -56.89%, reflecting the recent quarterly losses. This dramatic reversal highlights the fragility of the business model. Return on Capital Employed (ROCE) shows similar volatility, with an average of 2.24% but jumping to 25.39% in the latest period due to capital structure changes.
Critical Operational Red Flags
Zero Revenue Quarters: The company reported zero revenues in Q2 and Q3 FY26, indicating complete operational shutdown or business suspension during this period. This is highly unusual for an ongoing concern and raises serious questions about business continuity.
Margin Collapse: Operating margins swung from positive 5.22% in Q4 FY25 to negative 209.49% in Q4 FY26, suggesting either massive one-time write-offs or fundamental cost structure problems.
Negative Reserves: Accumulated losses of ₹8.02 crores despite capital infusion indicate a history of value destruction.
Cash Flow Dynamics: Severe Working Capital Strain
The cash flow statement for FY25 reveals significant stress. Despite reporting a profit before tax of ₹2.00 crores, cash flow from operations was deeply negative at ₹-16.00 crores, driven by adverse working capital changes of ₹-18.00 crores. This massive working capital consumption suggests inventory build-up, receivables expansion, or both—concerning trends for a trading business.
The company bridged this operational cash drain through financing activities, raising ₹14.00 crores (likely the capital infusion reflected in increased share capital). Net cash outflow for the year was ₹1.00 crore, with closing cash position at zero versus ₹2.00 crores at the start of FY25. This complete depletion of cash reserves leaves the company vulnerable to any further operational shocks.
Quality Assessment: Below Average Fundamentals
Newtrac Foods carries a "Below Average" quality grade based on long-term financial performance. Whilst the company demonstrates impressive 5-year sales growth of 168.70%, this is offset by weak profitability metrics, minimal institutional interest (0.33%), and volatile earnings. The positive aspects include zero promoter pledging and a net cash position, but these cannot compensate for the fundamental operational weaknesses exposed in recent quarters.
Peer Comparison: Struggling Against Sector Backdrop
Within the Trading & Distributors sector, Newtrac Foods' positioning reveals relative weaknesses despite some bright spots. The company's ROE of 16.01% (on an average basis) compares favourably with peers such as Khyati Global (15.46%) and Contil India (12.95%), but this metric is heavily distorted by the recent losses.
| Company | P/E (TTM) | P/BV | ROE (%) | Debt/Equity | Market Cap |
|---|---|---|---|---|---|
| Newtrac Foods | NA (Loss Making) | 2.83x | 16.01% | -0.08 | ₹34 Cr |
| Khyati Global | 6.70x | 1.20x | 15.46% | 0.45 | — |
| Contil India | 15.88x | 2.63x | 12.95% | 0.00 | — |
| Kaiser Corporation | NA (Loss Making) | 6.97x | 2.88% | 3.48 | — |
| Nirav Commercial | 228.21x | 1.13x | 1.62% | 0.00 | — |
Newtrac Foods' Price-to-Book ratio of 2.83x sits in the middle of the peer range but appears unjustified given current losses. The company's debt-free status (Debt/Equity of -0.08, indicating net cash) is a positive differentiator, but this advantage is rapidly eroding given negative cash flows and operational losses.
Valuation Analysis: Expensive Despite Collapse
Despite the operational meltdown, Newtrac Foods trades at what the valuation framework classifies as "Expensive." The Price-to-Book ratio of 2.83x seems unjustified for a loss-making entity with deteriorating fundamentals. The P/E ratio is not applicable given current losses, whilst the EV/EBITDA multiple of -4.32x reflects negative EBITDA.
The stock trades at ₹4.69, down 61.49% from its 52-week high of ₹12.18 but still 26.76% above its 52-week low of ₹3.70. This suggests the market has partially priced in the deterioration but may not fully reflect the severity of operational challenges. With a book value per share of ₹5.92, the stock trades at 0.79x book value on current price, but this book value itself may be overstated given recent losses.
Shareholding Pattern: Stable but Minimal Institutional Interest
The shareholding pattern reveals a concerning lack of institutional confidence. Promoter holding has remained static at 18.50% across the last five quarters, a relatively low level that suggests limited promoter conviction or capital constraints. Non-institutional shareholders dominate with 81.17%, indicating a largely retail investor base.
| Category | Mar'26 | Dec'25 | Sep'25 | Jun'25 | QoQ Change |
|---|---|---|---|---|---|
| Promoter | 18.50% | 18.50% | 18.50% | 18.50% | 0.00% |
| FII | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Insurance | 0.02% | 0.02% | 0.02% | 0.02% | 0.00% |
| Other DII | 0.31% | 0.31% | 0.31% | 0.31% | 0.00% |
| Non-Institutional | 81.17% | 81.17% | 81.17% | 81.17% | 0.00% |
Foreign Institutional Investors (FII) and Mutual Funds have zero exposure to the stock, whilst insurance companies hold a negligible 0.02% and other domestic institutional investors hold just 0.31%. Total institutional holding of 0.33% is exceptionally low and reflects the stock's micro-cap status and questionable fundamentals. The absence of institutional support means the stock lacks the anchor investors typically needed for stability during distress.
Stock Performance: Severe Underperformance Across All Timeframes
Newtrac Foods' stock performance has been disastrous across virtually all time periods. The one-year return of -52.63% compares unfavourably with the Sensex's -8.82% decline, resulting in a negative alpha of -43.81 percentage points. This massive underperformance extends across multiple timeframes, with the stock down 86.61% over two years whilst the Sensex gained 0.41%.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | -8.58% | -2.90% | -5.68% |
| 1 Month | -19.69% | -3.44% | -16.25% |
| 3 Months | -8.04% | -8.64% | +0.60% |
| 6 Months | -29.47% | -13.28% | -16.19% |
| YTD | -22.73% | -12.85% | -9.88% |
| 1 Year | -52.63% | -8.82% | -43.81% |
| 2 Years | -86.61% | +0.41% | -87.02% |
| 3 Years | -34.64% | +18.96% | -53.60% |
The stock's beta of 1.22 indicates higher volatility than the market, whilst its volatility of 54.24% compared to the Sensex's 13.06% underscores the extreme risk profile. The risk-adjusted return of -0.97 with a negative Sharpe ratio places this firmly in the "HIGH RISK LOW RETURN" category. The stock trades below all major moving averages, with technical indicators uniformly bearish.
Investment Thesis: Multiple Red Flags Dominate
The investment thesis for Newtrac Foods is overwhelmingly negative across all key parameters. The Mojo Score of 9 out of 100 places it in the bottom decile of investable stocks, with the "Strong Sell" rating reflecting fundamental, technical, and valuation concerns.
Key Strengths & Risk Factors
Key Strengths ✓
Debt-Free Balance Sheet: The company maintains zero long-term debt with a net cash position (Debt/Equity of -0.08).
No Promoter Pledging: Zero pledged shares indicate promoters haven't mortgaged holdings for loans.
Historical Growth: 5-year sales CAGR of 168.70% demonstrates past ability to scale operations.
Improved Shareholder Funds: Capital infusion moved shareholder funds from negative ₹5.02 crores to positive ₹11.18 crores.
Liquidity Position: Current ratio of approximately 1.69 provides some working capital cushion.
Key Concerns ⚠️
Massive Quarterly Loss: Q4 FY26 loss of ₹6.17 crores on revenues of just ₹2.95 crores indicates operational collapse.
Revenue Disappearance: Zero revenues in Q2 and Q3 FY26 suggest business suspension or severe disruption.
Negative Cash Flow: Operating cash flow of ₹-16.00 crores in FY25 despite profit indicates working capital stress.
Minimal Institutional Interest: Just 0.33% institutional holding reflects lack of confidence from sophisticated investors.
Negative Reserves: Accumulated losses of ₹8.02 crores indicate history of value destruction.
Volatile Margins: Operating margins swinging from +5.22% to -209.49% year-on-year shows business instability.
Low Promoter Holding: Just 18.50% promoter stake suggests limited skin in the game.
Outlook: Critical Monitoring Points
Positive Catalysts
Business Resumption: Any evidence of sustained revenue generation in coming quarters.
Margin Recovery: Return to positive operating margins indicating cost control.
Working Capital Improvement: Positive operating cash flows demonstrating business sustainability.
Strategic Clarity: Management communication on business model and growth strategy.
Red Flags to Watch
Continued Losses: Further quarterly losses would deplete shareholder funds rapidly.
Cash Depletion: Already at zero cash; any additional burn threatens viability.
Regulatory Issues: Trading suspensions or compliance problems given erratic operations.
Promoter Exits: Any reduction in already-low 18.50% promoter holding.
Debt Accumulation: Loss of debt-free status would severely constrain financial flexibility.
The Verdict: Exit Immediately or Avoid Completely
Score: 9/100
For Fresh Investors: Avoid completely. The company exhibits multiple signs of operational distress including two quarters of zero revenue, massive losses exceeding revenues, negative cash flows, and zero institutional interest. The micro-cap status and lack of business clarity make this an extremely high-risk proposition with minimal probability of recovery.
For Existing Holders: Exit immediately at current levels. The Q4 FY26 results represent a complete operational breakdown rather than cyclical weakness. With cash reserves depleted to zero, negative operating cash flows of ₹16.00 crores in FY25, and no visible path to profitability, the risk of further capital erosion is substantial. The 52.63% decline over the past year may only be the beginning if operations don't stabilise quickly.
Fair Value Estimate: Given current losses, negative trends, and business uncertainty, any valuation exercise is highly speculative. The stock trades near its 52-week low of ₹3.70, which may represent the floor only if operations resume. Without clear business recovery, fair value could be substantially lower, potentially approaching book value of ₹5.92 or below if losses continue. Downside risk: 20-40% from current levels if deterioration persists.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. The analysis presented is based on publicly available information as of June 2, 2026, and past performance is not indicative of future results. Micro-cap stocks carry significantly higher risks including liquidity constraints, operational volatility, and potential for total capital loss.
